Fulgent Genetics Stock Probability of Future Stock Price Finishing Under 13.27
| FLGT Stock | USD 18.07 0.18 1.01% |
Fulgent |
Fulgent Genetics Target Price Odds to finish below 13.27
The tendency of Fulgent Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 13.27 or more in 90 days |
| 18.07 | 90 days | 13.27 | near 1 |
Based on a normal probability distribution, the odds of Fulgent Genetics to drop to $ 13.27 or more in 90 days from now is near 1 (This Fulgent Genetics probability density function shows the probability of Fulgent Stock to fall within a particular range of prices over 90 days) . Probability of Fulgent Genetics price to stay between $ 13.27 and its current price of $18.07 at the end of the 90-day period is about 7.6 .
Given the investment horizon of 90 days Fulgent Genetics has a beta of 0.79. This usually indicates as returns on the market go up, Fulgent Genetics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Fulgent Genetics will be expected to be much smaller as well. Additionally Fulgent Genetics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Fulgent Genetics Price Density |
| Price |
Predictive Modules for Fulgent Genetics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Fulgent Genetics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Fulgent Genetics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Fulgent Genetics is not an exception. The market had few large corrections towards the Fulgent Genetics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Fulgent Genetics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Fulgent Genetics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.42 | |
β | Beta against Dow Jones | 0.79 | |
σ | Overall volatility | 1.69 | |
Ir | Information ratio | -0.17 |
Fulgent Genetics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Fulgent Genetics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Fulgent Genetics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Fulgent Genetics generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 289.21 M. Net Loss for the year was (167.82 M) with profit before overhead, payroll, taxes, and interest of 366.9 M. | |
| About 32.0% of the company shares are held by company insiders | |
| Latest headline from investing.com: Fulgent Genetics CEO Ming Hsieh sells 40,663 in stock |
Fulgent Genetics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Fulgent Stock often depends not only on the future outlook of the current and potential Fulgent Genetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fulgent Genetics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 29.8 M | |
| Cash And Short Term Investments | 424.2 M |
Fulgent Genetics Technical Analysis
Fulgent Genetics' future price can be derived by breaking down and analyzing its technical indicators over time. Fulgent Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Fulgent Genetics. In general, you should focus on analyzing Fulgent Stock price patterns and their correlations with different microeconomic environments and drivers.
Fulgent Genetics Predictive Forecast Models
Fulgent Genetics' time-series forecasting models is one of many Fulgent Genetics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Fulgent Genetics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Fulgent Genetics
Checking the ongoing alerts about Fulgent Genetics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Fulgent Genetics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Fulgent Genetics generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 289.21 M. Net Loss for the year was (167.82 M) with profit before overhead, payroll, taxes, and interest of 366.9 M. | |
| About 32.0% of the company shares are held by company insiders | |
| Latest headline from investing.com: Fulgent Genetics CEO Ming Hsieh sells 40,663 in stock |
Additional Tools for Fulgent Stock Analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.